Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATP7A Biomarker in Ovarian Cancer
NCT05490407Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Mar 2021
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by University Medical Centre Ljubljana. Primary endpoints: concentration of ceruloplasmin and expression of ATP7A. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT05490407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05490407.